Weight Loss Injections and Gallstones: Separating Fact from Fear

The misconception worth correcting first: it is the weight loss, not the jab, that drives the risk

A common worry circulating online is that weight-loss injections are uniquely dangerous for the gallbladder. The more accurate picture is that they are very effective medicines, and effective weight loss, achieved by any means, has long been associated with an increased risk of gallstone formation.

Here is the biology. When you lose weight quickly, your liver releases more cholesterol into bile. That cholesterol can crystallise, forming stones in the gallbladder. This is not a new observation: bariatric surgeons have known for decades that patients who lose weight rapidly after surgery have a substantially higher rate of gallstone development, often requiring a course of medication to prevent it. The same mechanism applies to diet-driven rapid loss. GLP-1 and dual-agonist medicines accelerate weight loss significantly, so the risk travels with the outcome, not with the molecule.

There is a secondary mechanism worth knowing. GLP-1 receptors are present in the gallbladder, and some research suggests GLP-1 agonists may modestly reduce gallbladder motility, which can contribute to bile stasis. The clinical significance of this in practice is still being studied. What is established is that the absolute risk of serious gallbladder events in the major trials remained low, even if it was higher than in placebo groups. The SURMOUNT-1 trial, published in the New England Journal of Medicine, recorded gallbladder-related disorders in a minority of tirzepatide participants, consistent with what is seen after meaningful weight loss by other routes.

So the risk is real and worth taking seriously. It is also contextualised by decades of evidence that obesity itself raises the risk of gallstones substantially. The clinical question is never whether weight loss carries some risk; it is whether the risks of not treating weight-related illness are greater.

What gallstones and gallbladder problems can look like on treatment

Most gallstones cause no symptoms at all. The ones that do tend to produce a fairly recognisable pattern: a cramping or aching pain in the upper right abdomen, often after a fatty meal, sometimes radiating to the right shoulder blade or mid-back. An attack can last minutes or several hours before easing.

More serious complications, such as cholecystitis (an inflamed gallbladder) or a stone blocking the bile duct, produce more persistent and severe pain, fever, nausea, and sometimes jaundice. These are medical emergencies, not something to manage with paracetamol until your next prescription review.

On a practical level, if you store your pen in the fridge door and notice any new or unusual abdominal pain in the weeks after starting treatment or after a dose increase, that is worth flagging to a clinician rather than ignoring it. Most abdominal discomfort on these medicines is gastrointestinal, transient, and resolves. But right-sided pain, especially if it persists or comes with fever, needs a proper assessment. The NHS tirzepatide page and the Mounjaro patient leaflet both list gallbladder disorders as reported side effects. The Yellow Card scheme at yellowcard.mhra.gov.uk exists precisely for reporting suspected side effects during treatment.

People with a history of gallstones often ask whether they can still consider treatment. That question is answered in more detail on our page on using weight-loss injections with a gallstone history, but the short version is that it depends on the clinical picture and is a conversation for a prescriber.

Does having had gallstones rule out weight-loss injections?

Not automatically. Gallstone history is a factor in the prescriber's assessment, not a blanket contraindication in the medicines' licences. What the prescriber will want to know: whether you have had your gallbladder removed (cholecystectomy), whether you have active gallbladder disease, and whether your gallstones are currently symptomatic. A person who had their gallbladder out years ago and has no current issues is in a very different position from someone with an inflamed gallbladder right now.

Active, symptomatic gallbladder disease is generally a reason to pause treatment or not start it, pending medical review. People with no gallbladder are not at the same risk from stones (you cannot form them without the gallbladder), though bile management can still be relevant after cholecystectomy.

This is one of several organ-specific questions worth raising at consultation. The clinical team at nume reviews every consultation personally, so if gallbladder history is part of your picture, it will be considered before any prescription is written. If the question is specifically about whether your existing gallstone situation rules you in or out, this page on taking weight-loss injections with gallstones goes into more clinical detail. And for context on how similar questions arise with kidney stones, the relationship between weight-loss injections and kidney stones follows a comparable framework.

It is also worth noting that the full range of weight-loss treatments available through nume covers both injectable and, as of summer 2026, oral options, which a prescriber may consider depending on your circumstances and medical history. A question our prescribers hear regularly is whether someone with GI-related concerns is a better candidate for one medicine over another, and if you are based in the city and wondering where to begin, you can read more about weight loss injections in Norwich on our dedicated local page. That kind of conversation is exactly what the consultation is for.